RxDoctor Payments Data

Vito Brunetti, MD

Otolaryngology · Wayne, NJNPI 1336261056

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Sanofi at 27.6% of the total. 2025 is the largest year on record at $885, 5.3 times the $166 reported in 2019.

$3,295in general payments, 2019–2025

Across 183 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$909
  • GSK$433
  • Optinose US, Inc.$406
  • Aerin Medical Inc.$373
  • Regeneron Healthcare Solutions, Inc.$275
  • CSL Behring$211
  • plus $689 from 19 others

What the payments were for

  • Food & beverage$3,295100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,295 in reported general payments places this provider in the 80th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$262,544
Medicare patients
652
Services billed
2,310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone231$23,209
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth57$8,598
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort128$6,832
Ipratropium Bromide138$3,782
Azelastine Hcl166$3,737
Fluticasone Propionate224$2,580
Mometasone Furoate15$1,729
Fluocinolone Acetonide Oil39$1,264
Mupirocin90$772
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort14$678
Montelukast Sodium34$463
Methylprednisolone77$445
CefuroximeCefuroxime Axetil39$344
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$286
Esomeprazole Magnesium15$216

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →